Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 183, pseudogene (RN7SL183P)

Target
RN7SL183P
Molecular classification
Pseudogene, Long non-coding RNA (lncRNA) pseudogene, Other
01

Overview

RN7SL183P (RNA, 7SL, cytoplasmic 183, pseudogene) is annotated as a *pseudogene* corresponding to the functional 7SL RNA gene, which encodes the central RNA component of the signal recognition particle (SRP) involved in cotranslational protein targeting to the endoplasmic reticulum[6][4][5]. Pseudogenes like RN7SL183P are DNA sequences that resemble functional genes but generally lack the capacity to produce functional RNAs or proteins due to disruptive mutations, frameshifts, or the absence of regulatory elements such as promoters[4]. While some pseudogenes are known to influence gene expression or function as long non-coding RNAs, there is currently no evidence that RN7SL183P itself has any direct biological function, therapeutic relevance, or disease involvement[6][4]. It is not considered a therapeutic target and should not be mistaken for the functional 7SL RNA (RN7SL1) gene, which is implicated in various cellular processes and has been studied in the context of cancer biology[1][3]. The listing for RN7SL183P is thus primarily of genomic and evolutionary interest, not as a drug or biomarker target.

Other names
RN7SL183P7SL RNA pseudogene7SL RNA, cytoplasmic 183, pseudogene
02

Biological functions

No known direct biological function (non-functional pseudogene)May participate in regulation of parent gene expression (only by analogy to described pseudogene functions[4])Other
03

Disease associations

Other (no direct evidence for disease involvement of this pseudogene)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 183, pseudogene (RN7SL183P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 183, pseudogene (RN7SL183P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call